Chesapeake Wealth Management Becton Dickinson & CO Transaction History

Chesapeake Wealth Management

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$215.77 - $276.76 $264,965 - $339,861	-1,228 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$219.9 - $263.41 $15,832 - $18,965	-72 Reduced 5.54%	1,228 $294,000
Q1 2020 Apr 29, 2020	SELL	$195.69 - $279.01 $7,436 - $10,602	-38 Reduced 2.84%	1,300 $298,000
Q4 2019 Jan 29, 2020	SELL	$236.45 - $266.82 $17,497 - $19,744	-74 Reduced 5.24%	1,338 $364,000
Q3 2019 Oct 25, 2019	SELL	$230.58 - $256.08 $49,805 - $55,313	-216 Reduced 13.27%	1,412 $358,000
Q2 2019 Aug 01, 2019	SELL	$217.4 - $246.08 $80,438 - $91,049	-370 Reduced 18.52%	1,628 $411,000
Q1 2019 Apr 17, 2019	SELL	$206.05 - $248.17 $250,762 - $302,022	-1,217 Reduced 37.85%	1,998 $498,000
Q4 2018 Feb 06, 2019	SELL	$204.73 - $257.93 $218,651 - $275,469	-1,068 Reduced 24.94%	3,215 $724,000
Q3 2018 Nov 14, 2018	BUY	$233.07 - $256.0 $24,239 - $26,624	104 Added 2.49%	4,283 $1.12 Million
Q2 2018 Aug 07, 2018	BUY	$208.1 - $233.85 $45,573 - $51,213	219 Added 5.53%	4,179 $1 Million
Q1 2018 Jun 04, 2018	BUY	$205.46 - $240.27 $813,621 - $951,469	3,960 New	3,960 $858,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Chesapeake Wealth Management with notifications on news.